P1.01-16 First-Line Pembrolizumab With or Without Chemotherapy in PD-L1 Positive NSCLC: A Network Meta-Analysis of Randomized Trials

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.572
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search